PAPER Weisz VI, Argibay PF
SEARCH RESULTS
329930 RESULTS
Coalition Against Major Diseases
CONFERENCE 2010-11-30 00:00:00-2010-11-30 00:00:00 Washington, D.C., U.S.A. 30 November 2010 0
Brain Mapping Day at the U.S. Congress, 2014
CONFERENCE 2014-05-20 00:00:00-2014-05-20 00:00:00 2168 Rayburn House Office Building (Gold Room), 45 Independence Ave. SW, Washington, D.C. 20 May 2014 A Congressional brief on the state-of-the-art in brain mapping, therapeutics, and translational multi-speciality neuroscience organized by the Society fo
Protein-Protein Interaction
CONFERENCE 2014-10-23 00:00:00-2014-10-24 00:00:00 Hyatt Regency, 1 Avenue De Lafayette, Boston, Massachusetts 23 October 2014 to 24 October 2014 The relatively new field of protein-protein interaction (PPI) is experiencing fantastic growth in the field of drug discovery. The key concepts of PPI are to un
Antibody and Protein Therapeutics
CONFERENCE 2014-10-23 00:00:00-2014-10-24 00:00:00 Hyatt Regency, 1 Avenue De Lafayette, Boston, Massachusetts 23 October 2014 to 24 October 2014 Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conju
Protein Expression, Purification, and Characterization
CONFERENCE 2014-10-23 00:00:00-2014-10-24 00:00:00 Hyatt Regency, 1 Avenue De Lafayette, Boston, Massachusetts 23 October 2014 to 24 October 2014 Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conju
Protein Discovery Summit 2014
CONFERENCE 2014-10-23 00:00:00-2014-10-24 00:00:00 Hyatt Regency, 1 Avenue De Lafayette, Boston, Massachusetts 23 October 2014 to 24 October 2014 The Protein DIscovery Summit provides access to more than 125 presentations from leading industrial and academic experts and will feature research findings, c
Patricia Hoffman
Jeongmin Lee
Korea, Republic of
Roxana Carare, Cheryl Hawkes, Roy Weller on Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
COMMENT This very interesting clinicopathological study identifies a number of risk factors for cerebral amyloid angiopathy (CAA) that, together with associated vascular lesions in the brain, may aid the clinical diagnosis of patients with CAA. Furthermore, the s
PAPER Charidimou A, Peeters A, Fox Z, Gregoire SM, Vandermeeren Y, Laloux P, Jäger HR, Baron JC, Werring DJ
Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis.
Stroke. 2012 Sep;43(9):2324-30. Epub 2012 Jul 12 PubMed: 22798323Luke A. Miles on Reports Weaken Death Receptor Link to Alzheimer's Disease
COMMENT Our unpublished look at this interaction showed by SPR and NMR that recombinant DR6 associates with APP via the disordered stalk domain, rather than the globular cys-rich domain. lmiles 0
Steven Greenberg on Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
COMMENT This recent analysis by Ringman and colleagues at the UCLA Alzheimer’s Disease Research Center teases out the clinical and pathological features conferred by advanced cerebral amyloid angiopathy (CAA) in the setting of Alzheimer’s disease (AD). The author
PAPER Dubal DB, Yokoyama JS, Zhu L, Broestl L, Worden K, Wang D, Sturm VE, Kim D, Klein E, Yu GQ, Ho K, Eilertson KE, Yu L, Kuro-o M, De Jager PL, Coppola G, Small GW, Bennett DA, Kramer JH, Abraham CR, Miller BL, Mucke L
Life extension factor klotho enhances cognition.
Cell Rep. 2014 May 22;7(4):1065-76. Epub 2014 May 10 PubMed: 24813892Bernadette Schreiner
Karolinska InstitutetHuddinge, Sweden
Current Filters
No filters selected